Protara Therapeutics Inc. buy BiotechBee
Start price
13.11.24
/
70%
€2.52
Target price
31.10.26
€4.00
Performance (%)
112.30%
End price
14.12.24
€5.35
Summary
This prediction ended on 14.12.24 with a price of €5.35. With a performance of 112.30% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protara Therapeutics Inc. | -2.814% | -2.814% | 28.182% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
According to BiotechBee what are the pros and cons of Protara Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Proteon Therapeutics Inc diskutieren
Buy mit Kursziel 4,0
In the thread Trading Protara Therapeutics Inc.
Buy beendet

